Evidence map›Paper›PMID 38779856›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

β-Aminopropionitrile Induces Distinct Pathologies in the Ascending and Descending Thoracic Aortic Regions of Mice.

Michael K Franklin, Hisashi Sawada, Sohei Ito, Deborah A Howatt, Naofumi Amioka, Ching-Ling Liang, Nancy Zhang, David B Graf, Jessica J Moorleghen, Yuriko Katsumata and 2 more

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Cautionary Data on Antihypertensives in Aortic Diseases.Hypertension (Dallas, Tex. : 1979) · 2026
    Article
  2. Article
  3. Article
  4. Mechanics and mechanobiology of arterial development.Biomechanics and modeling in mechanobiology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Fto-mediated m6A demethylation of Lox drives atrial fibrosis and promotes atrial fibrillation in a murine model of hyperthyroidism.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Michael K Franklin *Saha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-4993-0164
Hisashi Sawada *Saha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-0017-6236
Sohei ItoSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-1374-2946
Deborah A HowattSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-0078-092X
Naofumi AmiokaSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-5732-1951
Ching-Ling LiangSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0001-8154-4023
Nancy ZhangSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.
David B GrafSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0009-0001-3198-9865
Jessica J MoorleghenSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-2556-6719
Yuriko KatsumataDepartment of Biostatistics, College of Public Health (Y.K.), University of Kentucky, Lexington.ORCID 0000-0002-0188-8094
Hong S LuSaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-0577-2558
Alan DaughertySaha Cardiovascular Research Center (M.K.F., H.S., S.I., D.A.H., N.A., C.-L.L., N.Z., D.B.G., J.J.M., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-2093-3775

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Determinants of Aorta HeterogeneityR35HL155649 · NHLBI · UNIVERSITY OF KENTUCKY · PI Alan Daugherty · 2021 to 2026
$5.3M
NCATS NIH HHS UL1 TR001998NHLBI NIH HHS R35 HL155649NIA NIH HHS P30 AG072946
6 · The paper itself

Abstract

backgroundβ-aminopropionitrile (BAPN) is a pharmacological inhibitor of LOX (lysyl oxidase) and LOXLs (LOX-like proteins). Administration of BAPN promotes aortopathies, although there is a paucity of data on experimental conditions to generate pathology. The objective of this study was to define experimental parameters and determine whether equivalent or variable aortopathies were generated throughout the aortic tree during BAPN administration in mice.

methodsBAPN was administered in drinking water for a period ranging from 1 to 12 weeks. The impacts of BAPN were first assessed with regard to BAPN dose, and mouse strain, age, and sex. BAPN-induced aortic pathological characterization was conducted using histology and immunostaining. To investigate the mechanistic basis of regional heterogeneity, the ascending and descending thoracic aortas were harvested after 1 week of BAPN administration before the appearance of overt pathology.

resultsBAPN-induced aortic rupture predominantly occurred or originated in the descending thoracic aorta in young C57BL/6J or N mice. No apparent differences were found between male and female mice. For mice surviving 12 weeks of BAPN administration, profound dilatation was consistently observed in the ascending region, while there were more heterogeneous changes in the descending thoracic region. Pathological features were distinct between the ascending and descending thoracic regions. Aortic pathology in the ascending region was characterized by luminal dilatation and elastic fiber disruption throughout the media. The descending thoracic region frequently had dissections with false lumen formation, collagen deposition, and remodeling of the wall surrounding the false lumen. Cells surrounding the false lumen were predominantly positive for α-SMA (α-smooth muscle actin). One week of BAPN administration compromised contractile properties in both regions equivalently, and RNA sequencing did not show obvious differences between the 2 aortic regions in smooth muscle cell markers, cell proliferation markers, and extracellular components.

conclusionsBAPN-induced pathologies show distinct, heterogeneous features within and between ascending and descending aortic regions in mice.

Indexed as

AminopropionitrileAorta, ThoracicAortic RuptureDisease Models, AnimalMice, Inbred C57BLAge FactorsAnimalsCell ProliferationDilatation, PathologicFemaleMaleMiceMuscle, Smooth, VascularProtein-Lysine 6-OxidaseSex FactorsTime FactorsAminopropionitrileProtein-Lysine 6-Oxidaseaortaaorta, thoracicaortic aneurysmaortic dissectionprotein-lysine 6-oxidase

Identifiers

PMID38779856
PMCPMC11209774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.